(Q33851985)

29 July 2017

1 reference

title

Viral and immunopathogenesis of vertical HIV-1 infection (English)

1 reference

29 July 2017

Luzuriaga K

1

1 reference

29 July 2017

Sullivan JL

series ordinal

2

1 reference

29 July 2017

publication date

1 February 2000

1 reference

Pediatric Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

volume

47

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

65-78

1 reference

Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Incubation periods for paediatric AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Severe herpesvirus infections in an adolescent without natural killer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

HIV-1 infection in an individual homozygous for the CCR5 deletion allele

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Zoster in infancy: failure to maintain virus latency following intrauterine infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Proposed definitions for in utero versus intrapartum transmission of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Altered host range of HIV-1 after passage through various human cell types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Spoilt for choice of co-receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Induction of TH1 and TH2 immunity in neonatal mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Pre- and postexposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Perspectives series: host/pathogen interactions. Dynamics of HIV-1 replication in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Cytotoxic T Lymphocytes in Human Immunodeficiency Virus Infection: Responses to Structural Proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Virus escape from CTL recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Early viremia and immune responses in vertical human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Decay characteristics of HIV-1-infected compartments during combination therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Reduction of HIV concentration during acute infection: independence from a specific immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Chemokine receptors: gateways to inflammation and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Delayed generation of antibodies mediating human immunodeficiency virus type 1-specific antibody-dependent cellular cytotoxicity in vertically infected infants. WITS Study Group. Women and Infants Transmission Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Cytotoxic T lymphocytes in human immunodeficiency virus infection: regulator genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Role of Cellular Immunity in Protection against HIV Infection**This article was accepted for publication on 31 October 1996

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

HIV viral load markers in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Induction of protective CTL responses in newborn mice by a murine retrovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

CD4+ memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Neutralizing antibodies against sequential autologous human immunodeficiency virus type 1 isolates after seroconversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Differential tropism of HIV-1 isolates for distinct thymocyte subsets in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Pathogenesis of pediatric human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1-infected long-term nonprogressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

7 January 2021

Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

7 January 2021

Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

7 January 2021

Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970195-4

7 January 2021

10.1016/S0031-3955(05)70195-4

Identifiers

DOI

1 reference

29 July 2017

1 reference